CapSynth AI: A DeepTech platform providing a modular, enzyme-free chemical synthesis protocol for mRNA caps, integrated with an AI-driven process control system that optimizes reaction conditions in real-time to guarantee >95% purity and yield consistency, eliminating the single point of failure in mRNA supply chains.
Validated on That's Missing platform | Status: Active Opportunity
Market Catalyst & News Trigger
"FDA approves first fully synthetic mRNA-5' cap analog for off-the-shelf vaccine manufacturing"
The Workflow Friction
Current mRNA vaccine production relies on enzymatic capping, which is a bottleneck causing 30-40% yield loss, high enzymatic degradation costs, and inconsistent batch quality. Biopharma companies face $50M+ per batch failure risk and 6-month delays in emergency deployment due to supply chain fragility for specific enzymes.
Problem Summary
Real-world problem signal validation.
One-Shot MVP Builder Blueprint (48 Hours)
Dashboard: Real-time reaction monitoring UI. Core Flow: Input sequence length -> AI predicts optimal chemical reagent ratios -> Live sensor data integration for pH/temp -> Auto-adjustment of mixing speed -> Yield prediction report vs. historical enzymatic baseline.
Recommended Developer Tech Stack
- Python
- PyTorch
- PostgreSQL
- Kubernetes